AlperC.A., JohnsonA.M., BirtchA.G., MooreF.D.: Human C3: evidence for the liver as the primary site of synthesis.Science163, 286, 1969.
2.
AlperC.A., RaumD., AwdehZ.L., PetersenB.H., TaylorP.D., StarzlT.E.: Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, α1-antitrypsin, C8 and factor B.Clin. Immunol. Immunopathol.16, 84, 1980.
3.
BernardB.A., YamadaK.M., OldenK.: Carbohydrates selectively protect a specific domain of fibronectin against proteases.J. Biol. Chem.257, 8549, 1982.
4.
BergerE.G., BuddeckeE., KamerlingJ.P., KobataA., PaulsonJ.C., VliegenthartJ.F.G.: Structure, biosynthesis and functions of glycoprotein glycans.Experientia38, 1129, 1982.
5.
BlobelG., WalterP., ChangG.N., GoldmanB.M., EricksonA.H., LingappaV.R.: Translocation of proteins across membranes: the signal hypothesis and beyond.Symp. Soc. Exp. Biol.33, 9, 1979.
6.
BuskardN.A., GaltonD.A.G., GoldmanJ.M., KohnerE.M., GrindleC.F.J., NewmanD.L., TwinnK.W., LowenthalR.M.: Plasma exchange in the long-term management of Waldenström's macroglobulinemia. Can Med.Assoc. J.117, 135, 1977.
7.
de CeulaerC., PapazoglouS., WhaleyK.: Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and synovial membrane cells from patients with rheumatoid arthritis.Immunology41, 37, 1980.
8.
ClampJ.R.: Structure and function of glycoproteins. In: The Plasma Proteins, vol. II, 163, 1975. PutnamF.W. ed.; Academic Press, New York.
9.
CottierH.: Pathogenese, vol. I. Springer. Berlin1980.
10.
DavieE.W., HanahanD.J.: Blood coagulation proteins. In: The Plasma Proteins, vol. III, 421, 1977. PutnamF.W., ed.; Academic Press, New York.
11.
FerianiM., BiasioliS., ChiaromonteS., FabrisA., PisaniE., RoncoC., La GrecaG.: Anatomical bases of peritoneal permeability: a reappraisal. Anatomy of peritoneum.Int. J. Artif. Organs5, 345, 1982.
GralnickH.R., CreggerM.C., WilliamsS.B.: Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease.Blood59, 542, 1982.
16.
GralnickH.R., WilliamsS.B., RickM.E.: Role of carbohydrate in multimeric structure of factor Vlll/von Willebrand factor protein.Proc. Natl. Acad. Sci. USA80, 2771, 1983.
17.
HarrisJ.W., KellermayerR.W.: The Red Cell.Harvard Univ. Press.Harvard1974.
18.
HattonM.W.C., MärzL., RegoecziE.: On the significance of heterogeneity of plasma glycoproteins possessing N-glycans of the complex type: a perspective.Trends in Biochemical Sciences8, 287, 1983.
19.
JayeM., de la SalleH., SchamberF., BallandA., KohliV., FindeliA., TolstoshevP., LecocqJ.-P.: Isolation of human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonuteotide probe deduced from the amino acid sequence of bovine factor IX.Nucleic Acids Res.11, 2325, 1983.
20.
KarnowskyM.J.: The ultrastructural basis of capillary permeability studied with peroxidase as a tracer.J. Cell. Biol.35, 213, 1967.
21.
KornblihttA.R., Vibe-PedersenK., BaralleF.E.: Isolation and characterization of cDNA clones for human and bovine fibronectin.Proc. Natl. Acad. Sci.80, 3218, 1983.
22.
KurokawaT., SenoM., SasadaR., OnoY., OndaH., IgarashiK., KikuchiM., SaginoY., HonjoT.: Expression of human immunoglobulin E ∊ chain cDNA in E.coli. Nucleic Acids Res.11, 3077, 1983.
23.
LaurellC.-B., NymanM.: Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin.Blood12, 493, 1957.
24.
LawnR.M., AdelmanJ., BrockS.C., FrankeA.E., HouckC.M., NajarianR.C., SeeburgP.H., WionK.L.: The sequence of human serum albumin cDNA and its expression in E.coli. Nucleic Acids Res.9, 6103, 1981.
25.
LedgerP.W., NishimotoS.K., HayaskiS., TanzerM.L.: Abnormal glycosylation of human fibronectin secreted in the presence of monensin.J. Biol. Chem.258, 547, 1983.
26.
McMillanR., LongmireR., YelenoskyR.: The effect of corticosteroids on human LgG synthesis.J. Immunol.116, 1592, 1976.
27.
MillerL.L.: Hormonal regulation of net haptoglobin biosynthesis in the isolated perfused rat liver. In: Plasma protein turnover, 441, 1976. BianchiR., MarianiG., McFarlaneA.S., edts.; MacMillan Press, London.
28.
MillerL.L., BlyC.G., BaleW.F.: Plasma and tissue proteins produced by non-hepatic rat organs as studied with lysine-∊-C14.
29.
MorellA.G., GregoriardisG., ScheinbergI.H., HickmanJ., AshwellG.: The role of sialic acid in determining the survival of glycoproteins in the circulation.J. Biol. Chem.246, 1461, 1971.
30.
MorellA., TerryW.D., WaldmanT.A.: Metabolic properties of IgG subclasses in man.J. Clin. Invest.49, 673, 1970.
31.
NydeggerU.E.: Choice of the replacement fluid during large volume plasma exchange.Ric. Clin. Lab.13, 103, 1983.
32.
OrlinJ.B., BerkmanE.M.: Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents.Blood56, 1055, 1980.
33.
PandeH., CozkillJ., SailorR., ShivelyJ.E.: Comparative structural studies of human plasma and amniotic fluid fibronectins.Biochem. Biophys. Res. Commun.101, 265, 1981.
34.
PetersT.Jr..: Serum albumin. In: The Plasma Proteins, vol. I, 133, 1975. PutnamF.W., ed.; Academic Press, New York.
35.
Preud'hommeJ.-L.: Biochemical aspects of cellular immunoglobulin synthesis. In: Immunology, 521, 1982. BachJ.-F., ed.; J. Wiley and Sons, New York.
36.
RademacherT.W., DweckR.A.: Structural, functional and conformational analysis of immunoglobulin G-derived asparagine-linked oligosaccharides.Proc. Vth Int. Congr. Immunol. Immunology83, Academic Press.
37.
RosenoerV.M.: Protein turnover studies in the assessment of liver function. In: Plasma Protein Turnover, 103, 1976. BianchiR., MarianiG., McFarlaneA.S., edts.; MacMillan Press, London.
38.
RuoslahtiE., EngvallE., HaymanE.G., SpiroR.G.: Comparative studies on amniotic fluid and plasma fibronectins.Biochem. J.193, 295, 1981.
39.
RyffelB.: Experimental toxicological studies with cyclosporin A. In: Cyclosporin A, 45, 1982. WhiteD.J.G., ed.; Elsevier, Amsterdam.
40.
StackhouseR., ChandraT., RobsonK.J.H., WooS.L.C.: Purification of antithrombin III mRNA and cloning of its cDNA.J. Biol. Chem.258, 703, 1983.
41.
StarzlT.E., MarchioroT.L., RowlandsD.T.Jr., KirkpatrickC.H., WilsonW.E.C., RifkindD., WaddellW.R.: Immunosuppression after experimental and clinical homotransplantation of the liver.Ann. Surg.160, 411, 1964.
42.
TartakoffA.M.: Perturbation of vesicular traffic with the carboxylic ionophore monensin.Cell32, 1026, 1983.
43.
TavillA.S., CraigeA., RosenoerV.M.: The measurement of the synthetic rate of albumin in man.Clin. Sci34, 1, 1968.
44.
WagnerD.D., IvattR., DestreeA.T., HynesR.O.: Similarities and differences between the fibronectins of normal and trasformed hamster cells.J. Biol. Chem.256, 11708, 1981.
45.
WallevikK.: Shifts in the conformation of serum albumin and their possible significance in normal catabolism.Scand. J. Clin. Lab. Invest.38, 693, 1978.
46.
Wissenschaftliche Tabellen Geigy (Hämatologie und Humangenetik).Basel1979.
47.
YangF., BruneJ.L., BaldwinW.D., BarnettD.R., BowmannB.H.: Identification and characterization of human haptoglobin cDNA.Proc. Natl. Acad. Sci. USA80, 5875, 1983.
48.
ZwahlenA., NydeggerU.E., VaudauxP., LambertP.H., WalvogelF.A.: Complement mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis.J. Infect. Dis.145, 635, 1982.